The Evolving Clinical Picture of Chronic Prostatitis/chronic Pelvic Pain Syndrome (CP/CPPS): A Look at 1310 Patients over 16 Years
Overview
Affiliations
Introduction: Two decades of increasing understanding of etiopathogenesis and clinical phenotyping produces an impression the clinical face of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is changing. We sought to retrospectively analyze trends in CP/CPPS patients presenting to our clinic for evaluation over a 16-year period.
Methods: Patients with CP/CPPS presenting to a tertiary clinic were evaluated prospectively from 1998-2014 with Chronic Prostatitis Symptom Index (CPSI) and UPOINT (urinary, psychosocial, organ-specific, infection, neurogenic, and tenderness) categorization. Patients were stratified in four cohorts, based on year of presentation, and we retrospectively analyzed variations in symptom scores and patterns, UPOINT categorization, and treatment modalities amongst cohorts.
Results: Mean age of the 1310 CP/CPPS patients was 44.7 years, while mean CPSI pain, urination, and total scores were 10.6, 4.8, and 23.3, respectively. The most prevalent UPOINT domain, urinary (U) (71.8%) was associated with a higher CPSI urination score (6.3), more frequent penile tip pain (37%), dysuria (48%), and more treatment with alpha-blockers (70%). Increase in UPOINT domains was associated with higher CPSI pain, quality of life (QoL), and total scores. Trends over time included increased prevalence of psychosocial (P), organ (O), and tenderness (T) domains, as well as increased use of alpha-blockers, neuromodulation, and phytotherapy as treatment modalities. There was little variation in age, CPSI scores, and pain locations over time.
Conclusions: The changing clinical face of CP/CPPS reflects the increased recognition of psychosocial (P domain) and pelvic floor pain (T domain), along with the concomitant use of associated therapies. There was little variation of pain/urinary symptom patterns and QoL.
Origo D, Dal Farra F, Bruni M, Catalano A, Marzagalli L, Bruini I Int Urol Nephrol. 2022; 55(3):511-518.
PMID: 36522568 DOI: 10.1007/s11255-022-03448-2.
Santti R, Yatkin E, Bernoulli J, Streng T Vet Sci. 2022; 9(2).
PMID: 35202312 PMC: 8877003. DOI: 10.3390/vetsci9020060.
Brunahl C, Klotz S, Dybowski C, Albrecht R, Hoink J, Fisch M BMJ Open. 2021; 11(12):e053421.
PMID: 34907064 PMC: 8671982. DOI: 10.1136/bmjopen-2021-053421.
Efficacy and Safety of Drug Combinations for Chronic Pelvic Pain: Protocol for a Systematic Review.
Mohiuddin M, Park R, Wesselmann U, Pukall C, Jarvi K, Nickel C JMIR Res Protoc. 2021; 10(5):e21909.
PMID: 33999006 PMC: 8167620. DOI: 10.2196/21909.
Savoca M, Inferrera A, Verderio E, Caccamo D Mediators Inflamm. 2019; 2019:7894017.
PMID: 31360119 PMC: 6652054. DOI: 10.1155/2019/7894017.